Friday 6^th May 2022

13:45      Welcome and introduction (D. Betticher, Fribourg)

13:50      Update: Quality and reproducibility in breast cancer pathology (Z. Varga, Zürich)

14:20      Early detection – imaging update (R. Kubik, Baden)

14:50      Case presentation by attendees/discussion

15:15      Polygenig risk scores – music for the future or hot air? (S. Unger, Lausanne)

15:45      Coffee break

16:15      Mastectomy (S. Bucher, Luzern)

16:45      Update radiation therapy (G. Studer, Luzern)

17:15      Lymphedema: surgical update (M. Scaglioni, Luzern)

17:45      Quiz, Case presentation by attendees/discussion

18:30      Adjourn

Saturday 7^th May 2022

08:00      Response-adapted neoadjuvant therapy (H. Bonnefoi, Bordeaux)

08:40      Adjuvant HER2-targeted therapy (K. Zaman, Lausanne)

09:20      Optimum adjuvant endocrine therapy (L. del Mastro, Genova)

10:00      Coffee break

10:30      ER positive: CDK4/6 inhibitors and beyond (O. Pagani, Bellinzona)

11:00      Triple-negative and HER2-positive breast Cancer (M. Vetter, Liestal)

11:30      Lifestyle as supportive care? (C. Witt, Zürich)

12:00      Wrap up (D. Betticher)

12:15      End